For example, a two-photon imaging study of a ketamine and stress-induced mouse model of bipolar disorder, demonstrated that brain Ca 2+ activity measured in situ was reduced in mice displaying both manic and depressive-like behaviours [26]
In two-thirds of patients treated in the clinical trial, the studys authors report, these drugs also known as GLP-1 receptor agonists, because they mimic hormones that naturally create a feeling of fullness were able to reduce the inflammation responsible for fat buildup in the liver
It works by improving insulin sensitivity, which can help your body better manage sugar levels and prevent excess fat storage
However, there has also been a rapid rise in reports involving users who developed severe gastrointestinal problems, such as gastroparesis (stomach paralysis), ileus and intestinal blockages
There are definitely ways to mitigate these symptoms, though, and, at the end of the day, most people would rather deal with some minor inconveniences if they were able to lose 50+ pounds or more of weight, but these symptoms are still troublesome
And finally, this is not the last GLP-1 drug
